Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

15 results
Display

Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia

Scaramucci L, Giovannini M, Tendas A, Niscola P, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?

Palombi M, Scaramucci L, Giovannini M, Trawinska , Niscola P, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy

Niscola P, Tendas A, Scaramucci L, Giovannini M, Piccioni D, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome

Niscola P, Tendas A, Scaramucci L, Giovannini M, Fratoni S, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pure erythroid leukemia in advanced breast cancer

Niscola P, Tendas A, Minelli M, Perrotti A, de Fabritiis P, Del Poeta

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab

Tendas A, Niscola P, Scaramucci L, Cupelli L, Perrotti A, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary mixed-type autoimmune hemolytic anemia concomitant with acute splanchnic venous thrombosis of idiopathic origin in a young woman: an unexplained association

Scaramucci L, Giovannini M, Niscola P, Perrotti A, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy

Niscola P, Tendas A, Scaramucci L, Merola R, Catalano G, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent

Niscola P, Tendas A, Scaramucci L, Giovannini M, Fratoni S, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Regaining the response to erythropoietin following azacitidine in chronic myelomonocytic leukemia previously evolved from refractory anemia

Niscola P, Tendas A, Merola R, Orlandi G, Scaramucci L, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hematologists and nephrologists working together: moving forward with a new integrated care model for blood-related malignancies?

Niscola P, Caravita T, Tatangelo , Siniscalchi A, de Fabritiis P, Palumbo R

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis

Niscola P, Catalano G, Fratoni S, Scaramucci L, de Fabritiis P, Caravita T

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone

Niscola P, Palombi M, Fratoni S, Perrotti A, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin

Niscola P, Palombi M, Fratoni S, Trawinska , Scaramucci L, Tendas A, Giovannini M, Perrotti A, de Fabritiis P

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation

Niscola P, Grazia CD, Mazzone C, Tolu B, de Fabritiis P, Angelucci

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr